Characterization of the gammaherpes virus specific tegument protein, pORF52, in t
伽马疱疹病毒特异性外皮蛋白 pORF52 的表征
基本信息
- 批准号:8194010
- 负责人:
- 金额:$ 2.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-24 至 2013-09-23
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAlanineAntibodiesBacterial Artificial ChromosomesBindingBiochemicalBiological AssayCapsidCapsid ProteinsCell Culture TechniquesCellsCellular StructuresCentrifugationCodeComplementConfocal MicroscopyDNA biosynthesisDataDevelopmentFluorescence MicroscopyGoalsHomologous GeneHomologous ProteinHumanHuman Herpesvirus 8Imaging TechniquesImmunoblottingImmunofluorescence MicroscopyImmunoprecipitationIn VitroIndividualInfectionInvestigationKaposi SarcomaLaboratoriesLife Cycle StagesLymphomaLytic PhaseMacaca mulattaMalignant NeoplasmsMass Spectrum AnalysisMethodsMicrotubule StabilizationMicrotubulesModelingMonitorMulticentric Angiofollicular Lymphoid HyperplasiaMusMutationOpen Reading FramesPhenotypePlayProductionProteinsPublishingRelative (related person)RhadinovirusRoleScanningSeriesStagingStructural ProteinStructureSucroseTertiary Protein StructureTestingTimeTransfectionTransmission Electron MicroscopyTubulinViralViral GenomeViral ProteinsViral Structural ProteinsVirionVirusWorkbaseeffusionextracellulargamma-2 herpesvirusgammaherpesvirusinsightmutantparticleprotein expressionpublic health relevanceresearch studytumorviral DNAviral rescue
项目摘要
DESCRIPTION (provided by applicant): Rhesus monkey rhadinovirus (RRV), a gammaherpesvirus, is a close viral relative of Kaposi's sarcoma (KS)- associated herpesvirus (KSHV or HHV8), the causative agent of three human malignancies, Kaposi's Sarcoma (KS), primary effusion lymphoma, and multicentric Castleman's disease. RRV is an effective model to study the structure and assembly of gammaherpesviruses since it is able to produce high levels of progeny viruses in culture. The insights gained from studying mechanisms governing virally induced cancers can extend to a wide variety of malignancies, helping in the development of new treatments and therapies. Previous data from our laboratory have shown that RRV contains five gammaherpesvirus specific proteins in its tegument (middle) layer and of those, three have unknown functions, including the protein encoded by open reading frame 52, pORF52. Our hypothesis is that pORF52 plays a critical role in the structure of virions (viral particles) and their assembly as well as a potential role in cellular egress via a direct or indirect interaction with critical infrastructural components of the cell known as microtubules (MTs). Our methods of investigation include utilization of a wild-type (WT) RRV and an ORF52 deleted ( 52) RRV bacterial artificial chromosomes (BAC), each of which contains the remainder of the viral genome. Introducing these BACs into cells capable of supporting viral production will allow us to monitor the viral life cycle in the presence or absence of pORF52 production. The first goal will be to determine whether pORF52 is necessary for RRV DNA replication, a step preceding and required for progeny viral production. Quantitative analysis of the levels of individual viral proteins within the BAC containing cells will then help determine the requirement of pORF52 in the production of the various building block proteins necessary for viral assembly. In addition to these analyses, various imaging techniques will generate complementary data, helping us to examine the structure of the individual particles, the gross level of their production within the cells, as well as their intracellular localization and stage of maturation. In addition, media from cells containing either WT or 52 BAC will be assessed for a) infectious virus and b) production of structural viral proteins. Our preliminary results indicate that pORF52 is necessary for production of virus. To test this, 52 BAC containing cells will be complemented with the introduction of exogenous pORF52 and subsequently examined for the presence of infectious virions as described above. Additionally, RRV pORF52 expression by itself leads to its co-localization with, and stabilization of microtubules. Included in the second half of this proposal is a series of experiments that will investigate this potential interaction using microtubule binding assays, immunofluorescence and confocal microscopy, and assays that directly assess physical interactions between these two components. Combined with a series of mutations strategically introduced into pORF52, these approaches will allow the identification of the regions within the protein essential for not only its MT interactions but also its role in the viral life cycle.
PUBLIC HEALTH RELEVANCE: The insights gained from studying mechanisms governing virally induced cancers can extend to a wide variety of malignancies, helping in the development of new treatments and therapies. In this application, we propose to characterize the actions of one specific protein in the life cycle of a subfamily of tumor forming viruses called gammaherpesviruses. We hypothesize that this particular protein may play an essential role in the formation of new viral particles and, thus, would be an attractive candidate for targeted anti-viral therapy.
描述(由申请人提供):恒河猴病毒(RRV),一种伽马疱疹病毒,是卡波西肉瘤(KS)相关疱疹病毒(KSHV或HHV8)的近亲,卡波西肉瘤(KS)是三种人类恶性肿瘤的病原体、原发性渗出性淋巴瘤和多中心卡斯尔曼病。 RRV 是研究伽马疱疹病毒结构和组装的有效模型,因为它能够在培养物中产生高水平的子代病毒。从研究病毒诱发癌症的机制中获得的见解可以扩展到多种恶性肿瘤,有助于开发新的治疗方法和疗法。我们实验室之前的数据表明,RRV 在其皮层(中间)层含有 5 种伽马疱疹病毒特异性蛋白,其中 3 种具有未知功能,包括由开放阅读框 52、pORF52 编码的蛋白。我们的假设是,pORF52 在病毒粒子(病毒颗粒)的结构及其组装中发挥着关键作用,并且通过与细胞的关键基础设施成分(称为微管 (MT))直接或间接相互作用,在细胞流出中发挥潜在作用。我们的研究方法包括利用野生型 (WT) RRV 和 ORF52 删除 (52) RRV 细菌人工染色体 (BAC),其中每条都包含病毒基因组的其余部分。将这些 BAC 引入能够支持病毒产生的细胞中,将使我们能够在存在或不存在 pORF52 产生的情况下监测病毒生命周期。第一个目标是确定 pORF52 是否是 RRV DNA 复制所必需的,这是子代病毒产生之前的一步,也是必需的。对含有 BAC 的细胞内单个病毒蛋白水平的定量分析将有助于确定 pORF52 在生产病毒组装所需的各种构建块蛋白时的需求。除了这些分析之外,各种成像技术还将生成补充数据,帮助我们检查单个颗粒的结构、它们在细胞内产生的总体水平以及它们的细胞内定位和成熟阶段。此外,将评估来自含有 WT 或 52 BAC 的细胞的培养基的 a) 感染性病毒和 b) 结构病毒蛋白的产生。我们的初步结果表明pORF52对于病毒的产生是必需的。为了测试这一点,将通过引入外源pORF52来补充含有52个BAC的细胞,并随后如上所述检查感染性病毒粒子的存在。此外,RRV pORF52 表达本身导致其与微管共定位并稳定。该提案的后半部分包括一系列实验,将使用微管结合测定、免疫荧光和共聚焦显微镜以及直接评估这两种成分之间的物理相互作用的测定来研究这种潜在的相互作用。结合战略性地引入 pORF52 的一系列突变,这些方法将能够识别蛋白质内的区域,这些区域不仅对于 MT 相互作用至关重要,而且对于其在病毒生命周期中的作用也至关重要。
公共卫生相关性:从研究病毒诱发癌症的机制中获得的见解可以扩展到多种恶性肿瘤,有助于开发新的治疗方法和疗法。在本申请中,我们建议表征一种特定蛋白质在称为伽马疱疹病毒的肿瘤形成病毒亚科的生命周期中的作用。我们假设这种特殊的蛋白质可能在新病毒颗粒的形成中发挥重要作用,因此将成为靶向抗病毒治疗的有吸引力的候选者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melissa S Anderson其他文献
Melissa S Anderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melissa S Anderson', 18)}}的其他基金
Characterization of the gammaherpes virus specific tegument protein, pORF52, in t
伽马疱疹病毒特异性外皮蛋白 pORF52 的表征
- 批准号:
8307742 - 财政年份:2010
- 资助金额:
$ 2.87万 - 项目类别:
Characterization of the gammaherpes virus specific tegument protein, pORF52, in t
伽玛疱疹病毒特异性外皮蛋白 pORF52 的表征
- 批准号:
8061120 - 财政年份:2010
- 资助金额:
$ 2.87万 - 项目类别:
相似国自然基金
Mpro蛋白靶向亲和层析定向挖掘白及属中药抗新冠肺炎活性芪类成分
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
原子水平一体化构建腺相关病毒亲和层析介质及分子设计基础
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于凝集素芯片与凝集素亲和层析技术的参芪扶正注射液联合 IFN-α对肝癌切除术后复发转移干预机制的糖蛋白组学研究
- 批准号:81803954
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
基于生物质谱和亲和层析策略的大肠杆菌O157: H7特异性抗体的靶蛋白及多肽抗原表位的鉴定与研究
- 批准号:31701680
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
治疗SLE复方中的抗炎物质分离及对狼疮活动干预机制的研究
- 批准号:81673857
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Characterization of the gammaherpes virus specific tegument protein, pORF52, in t
伽马疱疹病毒特异性外皮蛋白 pORF52 的表征
- 批准号:
8307742 - 财政年份:2010
- 资助金额:
$ 2.87万 - 项目类别: